HSBC Holdings’s Immunomedics Inc IMMU Stock Holding History

HSBC Holdings’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-25,852	Closed	-$2.2M	–	3199
2020 Q3	$2.2M	Buy	25,852 +18,932	+274%	+$957K	﹤0.01%	1241
2020 Q2	$245K	Buy	+6,920	New	+$202K	﹤0.01%	2235
2020 Q1	–	Sell	-18,761	Closed	-$403K	–	3156
2019 Q4	$403K	Buy	+18,761	New	+$331K	﹤0.01%	2359
2017 Q1	–	Sell	-16,781	Closed	-$62K	–	2734
2016 Q4	$62K	Buy	+16,781	New	+$49.6K	﹤0.01%	2652

HSBC Holdings's IMMU Position: Q4 2020 in Review

HSBC Holdings sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 25,852 shares — an estimated $2.2M sold.

HSBC Holdings first reported a position in IMMU in Q4 2016 and held it in 4 quarters. The position peaked at $2.2M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

HSBC Holdings reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
HSBC Holdings sold 25,852 Immunomedics Inc shares in Q4 2020, an estimated $2.2M.
HSBC Holdings first reported a position in Immunomedics Inc in Q4 2016 and held it in 4 quarters.
HSBC Holdings's Immunomedics Inc position peaked at $2.2M in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on HSBC Holdings's 13F filing for Q4 2020, filed 12 Feb 2021.